BridgeBio Pharma Inc 2023 Sustainability Report
Company: BridgeBio Pharma Inc
Sector: Manufacturing
Country: United States
Year: 2023
Type: Sustainability Report
Pages: 40
The report describes an ESG governance structure led by an ESG Working Team that reports to the Board's Nominating & Corporate Governance Committee. Environmental priorities include efficient facilities, remote work, resource conservation, and hazardous-waste management. Social disclosures cover employee development, diversity and inclusion, patient engagement, access to medicines, and product safety; the report records 392 full-time and 4 part-time employees as of December 31, 2022. Governance disclosures address board diversity, business ethics, cybersecurity, clinical-trial standards, and vendor oversight.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.